Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
| ISIN: | DE000SLA5EB2 |
| Bloomberg Ticker: | SOLFUPHA Index |
| WKN: | SLA5EB |
Current Quotes
| Last quote (20 May 2025): | 623.23 |
| Day range: | 618.27 / 623.23 |
| Change abs./rel.: | 5.97 / 0.97% |
| Year range: | 544.13 / 711.97 |
| Name | Number of shares |
|---|---|
| SANOFI SA | 0.335898 |
| NOVO NORDISK A/S | 0.29127 |
| NOVARTIS AG | 0.332123 |
| SANDOZ GROUP AG | 0.45607 |
| GALDERMA GROUP AG | 0.20249 |
| SWEDISH ORPHAN BIOVITRUM AB | 0.632792 |
| ARGENX SE | 0.210617 |
| BAYER AG | 0.591223 |
| GSK PLC | 1.814132 |
| ROCHE HOLDING AG | 0.296657 |
| ASTRAZENECA PLC | 0.465155 |
| UCB SA | 0.430614 |
| MERCK KGAA | 0.10177 |
| RECORDATI SPA | 0.677898 |
| GENMAB A/S | 0.409759 |